Navigation Links
New Chief of Geriatric Psychiatry and Behavioral Health is Announced
Date:4/27/2009

icine, and is clinical assistant professor in medicine at the Keck-USC School of Medicine. He is a well-known speaker on topics relating to understanding and addressing the needs of seniors with depression, memory disorders and Alzheimer's disease.

"One reason I accepted the Jewish Home's offer to join its team is that the Home has mastered the clinical and compassionate side of taking care of our senior population in long-term care," says Dr. Nanda. "It's a hard transition for anyone to move from home to long-term care, and the Jewish Home and its very competent team of clinicians and management makes this transition easier."

Founded in 1912, the world-renowned Los Angeles Jewish Home is one of the foremost multi-level senior communities in the United States and is the largest single-source provider of senior housing in Los Angeles. In total the Home annually serves more than 1,700 seniors through an extraordinary continuum of services. Each year, more than 1,200 senior women and men are supported through in-residence housing on two village campuses (spanning 16 acres), with services featuring independent-living "Neighborhood Home" accommodations, residential care, skilled nursing care, Alzheimer's disease and dementia care. Another 500 seniors are served through the Home's community-based programs, which include Skirball Hospice and community clinics. Healthcare professionals from around the world consult with the Jewish Home in an effort to improve eldercare in their home countries. The Home is a nonprofit organization that relies upon donations from individuals, corporations and foundations to continue its remarkable work. Further information regarding the Home can be found online at jha.org or by calling 818-757-4407.


'/>"/>
SOURCE Los Angeles Jewish Home
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Scientx Groupe, S.A. Appointing Spinal Orthopedic Industry Executive Oliver Burckhardt as President and Chief Executive Officer
2. InfuSystem Appoints Bryan Russo as Chief Commercial Officer
3. BELLUS announces Chief Financial Officer to depart effective May 22, 2009
4. Prime Therapeutics Announces Departure of President and Chief Executive Officer Timothy Dickman
5. Halo Pharmaceutical Welcomes Dr. George Bobotas as Its Chief Scientific Officer
6. The Beryl Companies Hires Jim Stalder as New Chief Information Officer
7. MedQuist Names Dominick J. Golio as Chief Financial Officer
8. Medical Mutual of Ohio Names Dugan Chief Legal Counsel
9. John K. Davis, II to Join the American Board of Internal Medicine as Chief Information Officer
10. WaferGens Chief Scientific Officer to Deliver Executive Talk at Malaysian Ministry of Science, Technology and Innovations PCR Conference
11. Orexigen(R) Therapeutics Names Michael Narachi, 24-Year Biopharmaceutical Veteran, New President and Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... Longmont, CO, and Philadelphia, PA (PRWEB) November 24, ... a provider of care coordination and disease management ... organizations, has chosen to implement Essette’s Medical Management ... powerful new Essette SaaS platform in a program ... latest Essette suite includes Population Health Management, Care ...
(Date:11/24/2014)... 2014 "My friend was killed when ... cross the street in his motorized wheelchair," said an ... I came up with this idea so that people ... He developed the Safety Lites to make a wheelchair ... The device ensures that motorists can see the wheelchair. ...
(Date:11/23/2014)... For the coming special Friday, Tidebuy, a famous ... promotion for many products, especially the beautiful colored wedding ... choice with amazing discounts, up to 90% off. Don’t ... is easy to buy colored wedding dresses in different ... also famous for delicate craftsmanship, elegant style and perfect ...
(Date:11/23/2014)... November 23, 2014 Pro Ace Care, a ... it will now be providing an 8 year warranty on ... water tank installations went up due to the impending winter ... its customers of the premium service that the company provides. ... year warranty on John Wood and Bradford hot water tanks. ...
(Date:11/23/2014)... holidays can be a challenge for families of children ... an expert says. "Holidays with family can be ... have children with special needs, some care must be ... of the Sciences in Philadelphia, said in a university ... or visitors know what special requirements are needed to ...
Breaking Medicine News(10 mins):Health News:ReAdmission Solutions, LLC Selects Essette 2Health News:Beautiful Wedding Dresses Available at Popular B2C Company Tidebuy 2Health News:Pro Ace Care Now Gives 8 Year Guarantee on Selected Vancouver Hot Water Tanks 2Health News:Holidays Can Be Sensory Overload for Kids With Autism 2
... By Madonna Behen HealthDay Reporter , WEDNESDAY, Jan. ... killer in the world, and only about 15 percent of ... treatable. But two preliminary studies that are scheduled to ... scientists are moving closer to developing new screening tests that ...
... available in Spanish . , Let us assume ... GP is not sure what is wrong, and notes down on ... questions have been answered, the screen shows what the disease could ... to see such-and-such a specialist. Today this is utopia, but the ...
... lower risk of developing Type 2 diabetes, a disease on ... health problems? Scientists are offering a new solution to that ... Agricultural & Food Chemistry . Ling Zheng, Kun Huang ... are at a lower risk for developing Type 2 diabetes, ...
... fast-tracked through hospital emergency departments and operated on within ... developed by UK experts in anaesthesia, orthopaedics, geriatrics and ... Anaesthesia . However, patients in one ... longer than two days, risking lengthier inpatient stays, increased ...
... ,Surgeons aged 35 to 50 provide the safest care for ... about ongoing training and motivation of surgeons during their careers, ... France. They analyzed data from 3,574 thyroidectomies (removal of ... over a one-year period. The average age of the surgeons ...
... risks, but a new study shows that the consequences of ... function, according to a new study by University of Alabama ... of the Journal of the American Medical Association . ... in the United States, according to the National Survey on ...
Cached Medicine News:Health News:Tests Might Someday Help Spot Early Lung Cancer 2Health News:Tests Might Someday Help Spot Early Lung Cancer 3Health News:The keys to helping patients, on the GP's computer 2Health News:The keys to helping patients, on the GP's computer 3Health News:Hip fracture guidelines tackle 'considerable variations' in UK and Irish hospital care 2Health News:Hip fracture guidelines tackle 'considerable variations' in UK and Irish hospital care 3Health News:Surgeons in Mid-Career Have Fewest Complications: Study 2Health News:Marijuana smoke not as damaging to lungs as cigarette smoke 2Health News:Marijuana smoke not as damaging to lungs as cigarette smoke 3
(Date:11/24/2014)... SOUTH SAN FRANCISCO, Calif. , Nov. 24, 2014 /PRNewswire/ ... James M. Gower is retiring from the board ... executive officer, and Raul Rodriguez , most recently serving ... the position of chief executive officer and join the board ... Board of Directors since 2005, will become chairman. Mr. Gower ...
(Date:11/24/2014)... , Nov. 24, 2014  Inovio Pharmaceuticals, Inc. (NASDAQ: ... Joseph Kim , President and CEO of Inovio Pharmaceuticals, will ... team to ring the Nasdaq Opening Bell tomorrow, Tuesday November ... September 15 th listing on the Nasdaq Global Select ... Dr. Kim said, "We are honored to ring the Nasdaq ...
(Date:11/22/2014)...  Sprout Pharmaceuticals today announced positive preliminary results from a ... flibanserin up to 200 mg at bedtime had no next-day ... 20 th Annual Fall Scientific Meeting of the Sexual ... Miami . The Phase 1 ... Letter and the Formal Dispute Resolution that was filed in ...
Breaking Medicine Technology:Rigel Announces Executive Management Changes 2Rigel Announces Executive Management Changes 3Inovio Pharmaceuticals to Ring Opening Bell Nov 25th on the Nasdaq Stock Market 2Inovio Pharmaceuticals to Ring Opening Bell Nov 25th on the Nasdaq Stock Market 3Sprout Pharmaceuticals Presents Phase 1 Clinical Trial Data Showing Treatment With Flibanserin Results In No Next-Day Driving Impairment 2Sprout Pharmaceuticals Presents Phase 1 Clinical Trial Data Showing Treatment With Flibanserin Results In No Next-Day Driving Impairment 3
... Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ) today ... 2) in gout patients initiating allopurinol therapy, ARCALYST (rilonacept) ... primary endpoint was the number of gout flares per ... ARCALYST at a weekly, self-administered, subcutaneous dose of either ...
... Feb. 28, 2011 Nile Therapeutics, Inc. (Nasdaq: ... development of novel therapeutics for cardiovascular disease, announced plans ... heart failure.  Nile plans to develop cenderitide (formerly CD-NP) ... decompensated heart failure (ADHF) patients continuously for up to ...
Cached Medicine Technology:ARCALYST® (rilonacept) Meets Primary and All Secondary Endpoints in Second Phase 3 Trial for Prevention of Gout Flares in Patients Initiating Uric Acid-Lowering Therapy 2ARCALYST® (rilonacept) Meets Primary and All Secondary Endpoints in Second Phase 3 Trial for Prevention of Gout Flares in Patients Initiating Uric Acid-Lowering Therapy 3ARCALYST® (rilonacept) Meets Primary and All Secondary Endpoints in Second Phase 3 Trial for Prevention of Gout Flares in Patients Initiating Uric Acid-Lowering Therapy 4ARCALYST® (rilonacept) Meets Primary and All Secondary Endpoints in Second Phase 3 Trial for Prevention of Gout Flares in Patients Initiating Uric Acid-Lowering Therapy 5ARCALYST® (rilonacept) Meets Primary and All Secondary Endpoints in Second Phase 3 Trial for Prevention of Gout Flares in Patients Initiating Uric Acid-Lowering Therapy 6ARCALYST® (rilonacept) Meets Primary and All Secondary Endpoints in Second Phase 3 Trial for Prevention of Gout Flares in Patients Initiating Uric Acid-Lowering Therapy 7ARCALYST® (rilonacept) Meets Primary and All Secondary Endpoints in Second Phase 3 Trial for Prevention of Gout Flares in Patients Initiating Uric Acid-Lowering Therapy 8ARCALYST® (rilonacept) Meets Primary and All Secondary Endpoints in Second Phase 3 Trial for Prevention of Gout Flares in Patients Initiating Uric Acid-Lowering Therapy 9ARCALYST® (rilonacept) Meets Primary and All Secondary Endpoints in Second Phase 3 Trial for Prevention of Gout Flares in Patients Initiating Uric Acid-Lowering Therapy 10Nile Therapeutics Announces Plans to Pursue a Post-Acute Indication in Heart Failure 2Nile Therapeutics Announces Plans to Pursue a Post-Acute Indication in Heart Failure 3Nile Therapeutics Announces Plans to Pursue a Post-Acute Indication in Heart Failure 4
The A350 test is used for POC testing in hospital emergency departments, replacing the need to draw blood for alcohol testing. Each hash mark is 0.02% or 20 mg/dL....
... Tests are available in 14 configurations including ... using Microgenics Antibody Technology, the SureStep™ MDMA ... care immunoassay targeted to detect MDMA that ... MDEA but no cross-reactivity to any isomer ...
... Drug Screen Tests are available in 14 ... (Ecstasy). Designed using Microgenics Antibody Technology, the ... point of care immunoassay targeted to detect ... MDA and MDEA but no cross-reactivity to ...
... SureStep™ Drug Screen Tests are available in ... MDMA (Ecstasy). Designed using Microgenics Antibody Technology, ... only point of care immunoassay targeted to ... both MDA and MDEA but no cross-reactivity ...
Medicine Products: